Pediatric Oncology Drug Development: A Case Report and Pathways Forward
- *Corresponding Author:
- John M. Goldberg
Assistant Professor of Clinical Pediatrics Director
Pediatric Oncology Early Phase Clinical Trials Program
UM Sylvester Comprehensive Cancer Center Division of Pediatric
Hematology/Oncology(D-820) P.O. Box 016960 Miami, Florida 33101 USA
E-mail: [email protected]
Received Date: March 24, 2014; Accepted Date: April 24, 2014; Published Date: April 26, 2014
Citation: Goldberg JM, Panoff J (2014) Pediatric Oncology Drug Development: A Case Report and Pathways Forward. Pediat Therapeut 4:202. doi: 10.4172/2161-0665.1000202
Copyright: © 2014 Goldberg JM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
In this case report, we briefly review the treatment of a patient with metastatic, refractory Ewing's sarcoma who was treated on a Phase I clinical trial before she died from progressive disease. The case illustrates the need for early phase clinical trials programs in pediatric oncology, and the way in which investigators approach such programs.